Serum Fatty Acids and Inflammatory Patterns in Severe Obesity: A Preliminary Investigation in Women
Authors:
- Gislene B. LimaGLGislene B. Lima
- Nayra FigueiredoNFNayra Figueiredo
- Fabiana M. KattahFKFabiana M. Kattah
- Emilly S. OliveiraEOEmilly S. Oliveira
- Maria A. HorstMaria A. Horst
- Ana R. DâmasoADAna R. Dâmaso
- Lila M. OyamaLOLila M. Oyama
- Renata G. M. WhittonRWRenata G. M. Whitton
- Gabriel I. M. H. de SouzaGSGabriel I. M. H. de Souza
- Glaucia C. LimaGLGlaucia C. Lima
- João F. MotaJMJoão F. Mota
- Raquel M. S. CamposRCRaquel M. S. Campos
Open Access
- 3 October 2024
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 12 (10) , 2248
Abstract
Background: Inflammation plays a central role in many chronic diseases that characterize modern society. Leptin/adiponectin and adiponectin/leptin ratios have been recognized as notable markers of dysfunctional adipose tissue and, consequently, an inflammatory state. Methods: Blood samples were collected from 41 adult volunteers (40.2 ± 8.3 years) diagnosed with severe obesity (BMI 46.99; 42.98–51.91 kg/m2). The adipokines were quantified using an enzyme-linked immunosorbent assay, while the serum fatty acid analysis was conducted using chromatography. Results: The results unveiled a positive correlation between the leptin/adiponectin ratio and the 20:3n6 fatty acid (r = 0.52, p = 0.001), as well as a similar positive correlation between the adiponectin/leptin ratio and the 22:6n3 fatty acid (r = 0.74, p = 0.001). In the regression analysis, the 22:6n3 fatty acid predicted the adiponectin/leptin ratio (β = 0.76, p < 0.001), whereas C20:3 n-6 was a predictor for inflammatory markers (β = 4.84, p < 0.001). Conclusions: In conclusion, the 22:6n3 fatty acid was demonstrated to be a predictive factor for the adiponectin/leptin ratio and C20:3 n-6 was a predictor for inflammatory markers. This discovery, novel within this population, can help develop new intervention strategies aimed at controlling the inflammatory status in individuals classified as having severe obesity.Keywords
Funding Information
- National Council for Scientific and Technological Development—CNPq (434159/2018-2, n. 305240/2021-8)
- Research Support Foundation—FUNAPE–UFG (434159/2018-2, n. 305240/2021-8)
This publication has 39 references indexed in Scilit:
- Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19Diabetes & Metabolism, 2021
- Influence of magnitude of weight loss on Adipo/lep ratio in adolescents with obesity undergoing multicomponent therapyCytokine, 2020
- Fatty acids, eicosanoids and PPAR gammaEuropean Journal of Pharmacology, 2016
- Leptin and incident cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis (MESA)Atherosclerosis, 2015
- Roux-en-Y Gastric Bypass Decreases Pro-inflammatory and Thrombotic Biomarkers in Individuals with Extreme ObesityObesity Surgery, 2014
- Hyperleptinemia: Implications on the Inflammatory State and Vascular Protection in Obese Adolescents Submitted to an Interdisciplinary TherapyInflammation, 2013
- Adiponectin-leptin ratio: A useful estimate of insulin resistance in patients with Type 2 diabetesJournal of Endocrinological Investigation, 2010
- Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseasesBiomedicine & Pharmacotherapy, 2006
- Polyunsaturated fatty acids, inflammation, and immunityLipids, 2001
- An endoperoxide aggregator (LASS), formed in platelets in response to thrombotic stimuli-purification, identification and unique biological significanceProstaglandins, 1974